Cellvizio is the real-time, in vivo cellular imaging platform to perform Confocal Laser Endomicroscopy (CLE). CLE is used in our facility for diagnosis of Barrett’s esophagus and any tendency towards cancer in patients with Barrett’s esophagus. This unique advanced imaging technology enables physicians to see tissue at the microscopic level during an endoscopic examination, facilitating traditional tissue sampling and speeding up the process between examination, diagnosis, and intervention.
As an enhancement of your EGD, Cellvizio enables your physician to accelerate diagnosis, better inform treatment, and improve therapy delivery. With 19 U.S. FDA 510(k) clearances, Cellvizio is clinically proven to be a safe and effective tool. This well-tested and state-of-the-art technology has positively impacted the lives of patients like you across the world who have benefitted from a more accurate and timely diagnosis.
To learn more about Cellvizio, visit https://diagnosingbarretts.org/ and contact Gastro Office to see if a Cellvizio procedure is right for you.